Bio-Techne Corporation
USD50.79
-0.89 (-1.72%)
CEO
Kim Kelderman
IPO Date
1989-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$51.45
Prev. Close
$51.68
Day Low
$50.63
Day High
$51.80
52W Low
$43.20
52W High
$72.16
Market Cap
$7.95B
Volume
2.19M
| $48.28 |
| 12 May 2026 | Herr Amy E. | director | M-Exempt | Disposed | 6,636 | $47.60 |
| 7 May 2026 | Hippel James | CFO | M-Exempt | Acquired | 62,000 | $47.60 |
| 7 May 2026 | Hippel James | CFO | F-InKind | Disposed | 56,955 | $56.68 |
| 7 May 2026 | Hippel James | CFO | M-Exempt | Disposed | 62,000 | $47.60 |
| 7 May 2026 | Bohnen Shane | SVP - General Counsel | M-Exempt | Acquired | 8,400 | $47.60 |
| 7 May 2026 | Bohnen Shane | SVP - General Counsel | F-InKind | Disposed | 7,055 | $56.68 |
| 7 May 2026 | Bohnen Shane | SVP - General Counsel | M-Exempt | Disposed | 8,400 | $47.60 |
| 7 May 2026 | Kelderman Kim | director, officer: Chief Executive Officer | M-Exempt | Acquired | 26,692 | $47.60 |
| April Delaney |
| Sale |
| $1,001 - $15,000 |
| 8 Apr 2026 | April Delaney | April Delaney | Sale | $1,001 - $15,000 |
| 8 Apr 2026 | April Delaney | April Delaney | Sale | $1,001 - $15,000 |
| 11 Mar 2026 | April Delaney | April Delaney | Sale | $1,001 - $15,000 |
| 11 Mar 2026 | April Delaney | April Delaney | Sale | $1,001 - $15,000 |
| 3 Feb 2026 | April Delaney | April Delaney | Sale | $1,001 - $15,000 |
| 6 Jan 2026 | April Delaney | April Delaney | Purchase | $1,001 - $15,000 |
| 6 Jan 2026 | April Delaney | April Delaney | Purchase | $1,001 - $15,000 |
| 5 Nov 2025 | April Delaney | April Delaney | Purchase | $1,001 - $15,000 |
| 3 Sept 2025 | April Delaney | April Delaney | Sale | $1,001 - $15,000 |